FDA Authorizes Pharmacists to Prescribe Pfizer's COVID-19 Therapy

The FDA authorized  state-licensed pharmacists to prescribe, with certain limitations, Pfizer Inc's  (NYSE: PFE ) COVID-19 pill to eligible patients to help improve access to the treatment. "Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients," Patrizia ... Full story available on Benzinga.com